{"data":{"id":"us-sd/sdcl-58-29g-3","jurisdiction":"us-sd","citation":"SDCL § 58-29G-3","heading":"Requiring claim or utilization data restricted--Exclusion.","body":"A pharmaceutical manufacturer may not, directly or indirectly, require a 340B entity or pharmacy to submit any claim or utilization data, as a condition for allowing the acquisition of a 340B drug by, or delivery of a 340B drug to, a 340B entity, unless the claim or utilization data sharing is required by federal law.\nNothing in this section prohibits a pharmaceutical manufacturer from conducting an audit of a 340B entity, in accordance with 42 U.S.C. § 256b(a)(5)(C) (January 1, 2025).","path":["TITLE 58. INSURANCE","CHAPTER 58-29G. DRUG DISCOUNT PROGRAM PROTECTIONS"],"source_url":"https://sdlegislature.gov/Statutes/58-29G-3","current_through":"2026-08-31","vintage":"","retrieved_at":"2026-09-03T15:18:57Z","sha256":"9c80e8d66ea11770004ccc7b634249e6766a9e41aa9cef7d11df4e0aaf49ea66","source_id":"us-sd","stale":true,"prev":"us-sd/sdcl-58-29g-2","next":"us-sd/sdcl-58-29g-4"},"notice":"GroundRules: Original legal text. Not legal advice."}